OMKAR SPECIALITY CHEMICALS LTD.

Omkar Speciality Chemicals Limited announced its audited standalone financial results for the quarter and financial year ended March 31, 2026. The Board of Directors also approved the formation of a Nomination and Remuneration Committee and a change in the registered office address. The company's financial statements were prepared on a going concern basis, with attention drawn to a Resolution Plan approved via an order dated July 31, 2025, which has been given effect in the financial statements. The auditor's report confirmed that the financial statements provide a true and fair view, though it highlighted the impact of the Resolution Plan and the going concern basis.

Omkar Speciality Chemicals Limited announced the outcome of its Board of Directors meeting held on June 12, 2026. The board approved the standalone audited financial statements for the quarter and financial year ended March 31, 2026. Additionally, the company's board approved the constitution of a Nomination and Remuneration Committee (NRC) with Mr. Bhupeshkumar Jain as Chairperson. The board also approved a change in the registered office address within local limits. The meeting commenced at 4:00 p.m. and concluded at 7:35 p.m. The company is currently admitted into Corporate Insolvency Resolution Process (CIRP).

Omkar Speciality Chemicals Ltd has announced a Board of Directors meeting scheduled for June 12, 2026. The meeting will primarily focus on approving the audited financial statements for the quarter and financial year ended March 31, 2026. Additionally, the board will consider a change in the company's registered office address within the same city/town/village. This announcement is made in compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The Monitoring Committee of Omkar Speciality Chemicals Limited, in its meeting on May 27, 2026, approved the unaudited financial statements for the quarters ended June 30, 2025, September 30, 2025, and December 31, 2025. The committee also approved the constitution of the Audit Committee and the Stakeholder's Relationship Committee of the Board. Furthermore, Mr. Ruhini Kumar Chakraborty was appointed as an Independent Director, and Mr. Dipak Kumar Shaw was appointed as the Chief Executive Officer (CEO) of the Company. The company is currently under Corporate Insolvency Resolution Process (CIRP).

The Monitoring Committee of Omkar Speciality Chemicals Limited, in its meeting held on May 27, 2026, approved the unaudited financial results for the quarters ended June 30, 2025, September 30, 2025, and December 31, 2025. Additionally, the committee approved the constitution of the Audit Committee and the Stakeholder's Relationship Committee of the Board. Key management changes were also approved, including the appointment of Mr. Ruhini Kumar Chakraborty as an Independent Director and Mr. Dipak Kumar Shaw as the Chief Executive Officer (CEO). The company remains under Corporate Insolvency Resolution Process (CIRP) since December 5, 2022.

The Monitoring Committee of Omkar Speciality Chemicals Limited, currently under Corporate Insolvency Resolution Process (CIRP), approved the unaudited financial statements for the quarters ended June 30, 2025, September 30, 2025, and December 31, 2025. The committee also approved the constitution of the Audit Committee and the Stakeholder's Relationship Committee. Additionally, Mr. Ruhini Kumar Chakraborty was appointed as an Independent Director, and Mr. Dipak Kumar Shaw was appointed as the Chief Executive Officer (CEO) of the company.

Omkar Speciality Chemicals Ltd has scheduled a Board of Directors meeting on May 27, 2026, to consider and approve several key items. These include the unaudited financial statements for the quarters ended June 30, 2025, September 30, 2025, and December 31, 2025, the constitution of the Audit Committee and Stakeholder’s Relationship Committee, and the appointment of Mr. Ruhini Kumar Chakraborty as an Independent Director. The board will also consider the appointment of Mr. Dipak Kumar Shaw as CEO, the appointment of Statutory Auditors, the appointment of a Secretarial Auditor for FY 2025-26, opening a current bank account with ICICI Bank, discussing CIRP costs and refund of PBG.

Omkar Speciality Chemicals Ltd has detailed a broad step plan following its Resolution Plan approved under the Insolvency and Bankruptcy Code, 2016. The plan involves several key actions: first, the entire share capital will be reduced to NIL as per the NCLT order dated July 31, 2025. Second, the company will issue fresh equity shares of face value ₹10 each to the Resolution Applicant (RA) after obtaining an enabling resolution and in-principle approval from stock exchanges. Post allotment, the RA will hold 100% of the company's paid-up capital. Finally, to comply with SEBI regulations, the company will undertake an Offer for Sale (OFS) of 5% of equity shares held by the promoter/promoter group through the stock exchange mechanism to achieve Minimum Public Shareholding (MPS).

Omkar Speciality Chemicals Ltd. announced the implementation of its NCLT-approved Resolution Plan. The Monitoring Committee approved the cancellation of all existing equity shares (promoter and public) of INR 10 each, setting April 29, 2026, as the record date. Concurrently, 50,00,000 new equity shares of INR 10 each, totaling INR 5,00,00,000, will be issued at par to IFFAS Kshitij SPV LLP on a private placement basis. The company also approved raising a loan of up to INR 20,00,00,000 from Kshitij Polyline Limited and treating an earnest money deposit of INR 2,190 lakhs as debt/loan under the plan. Additionally, Mr. Mahendra Kumar Jain has been appointed as the new Chief Financial Officer. These actions are part of the company's restructuring following its admission into CIRP in December 2022.

Omkar Speciality Chemicals Ltd has fixed April 29, 2026, as the record date for the extinguishment/cancellation of its paid-up share capital. This action applies to all equity shares of INR 10 each held by both existing promoters and promoter groups, and existing public shareholders. The decision was made by the Company's Monitoring Committee on April 15, 2026, and is in accordance with a Resolution Plan approved by the National Company Law Tribunal (NCLT), Mumbai bench, via an order dated July 31, 2025. The company was admitted into CIRP on December 5, 2022. This corporate action is a significant step in the company's insolvency resolution process.